Feasibility and tolerability of bone impact microindentation testing: a cross-sectional, population-based study in Australia

Rufus-Membere, Pamela, Holloway-Kew, Kara L., Diez-Perez, Adolfo, Kotowicz, Mark A. and Pasco, Julie A. 2018, Feasibility and tolerability of bone impact microindentation testing: a cross-sectional, population-based study in Australia, BMJ open, vol. 8, no. 12, doi: 10.1136/bmjopen-2018-023959.

Attached Files
Name Description MIMEType Size Downloads

Title Feasibility and tolerability of bone impact microindentation testing: a cross-sectional, population-based study in Australia
Author(s) Rufus-Membere, Pamela
Holloway-Kew, Kara L.
Diez-Perez, Adolfo
Kotowicz, Mark A.ORCID iD for Kotowicz, Mark A. orcid.org/0000-0002-8094-1411
Pasco, Julie A.ORCID iD for Pasco, Julie A. orcid.org/0000-0002-8968-4714
Journal name BMJ open
Volume number 8
Issue number 12
Article ID e023959
Total pages 5
Publisher BMJ Publishing
Place of publication London, Eng.
Publication date 2018-12-22
ISSN 2044-6055
Keyword(s) OsteoProbe
bone material strength index
fractures
microidentation
Summary OBJECTIVES: The OsteoProbe measures Bone Material Strength Index (BMSi) of cortical bone in living humans using impact microindentation (IMI). Research using this minimally invasive technique is expanding yet, to-date, there have been no reports about its feasibility in the research setting. In this study, we assessed the feasibility and tolerability of using the OsteoProbe in men enrolled in the Geelong Osteoporosis Study. DESIGN: Cross-sectional analysis of data collected in a population-based study. SETTING: Barwon Statistical Division, southeastern Australia, 2016-2018. METHODS: For 252 of 345 consecutive participants (ages 33-96 years), BMSi was measured using the OsteoProbe at the mid-tibia. Immediately following measurement, each participant used a Visual Analogue Scale (0-10) to rate the level of discomfort that was anticipated and experienced, their initial reluctance towards the measurement and their willingness to repeat measurement. RESULTS: Reasons for non-measurement in 92 men were needle phobia (n=8), discomfort after first indentation (n=5), skin infections (n=21), excessive soft tissues around the mid-tibia region (n=56), inability to provide informed consent (n=2). Among 252 men who had IMI measures, the expectation for pain during measurement was low (1.54±1.56), as was actual pain experienced (0.38±0.71). Reluctance to undergo measurement was low (0.34±0.93). All participants indicated a willingness to have the measurement performed again. Mean (±SD) BMSi was 83.0±6.4 (range 62.3-93.0). CONCLUSION: In this study, the procedure was well accepted by participants suggesting that IMI testing with the OsteoProbe is feasible in a research setting.
Language eng
DOI 10.1136/bmjopen-2018-023959
HERDC Research category C1 Refereed article in a scholarly journal
Copyright notice ©2018, The Authors
Persistent URL http://hdl.handle.net/10536/DRO/DU:30117408

Document type: Journal Article
Collections: School of Medicine
Open Access Checking
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in TR Web of Science
Scopus Citation Count Cited 0 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 0 Abstract Views, 0 File Downloads  -  Detailed Statistics
Created: Thu, 31 Jan 2019, 10:37:10 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.